Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
GL ›
GLYSOMED. GIRLFRIEND RECOMMENDED
Trademark search for:
GLYSOMED. GIRLFRIEND RECOMMENDED
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-11-15 — Application filed
2005-11-21 — Application filed
2006-03-08 — Teas change of correspondence received
2006-05-17 — Assigned to examiner
2006-05-18 — Approved for pub - principal register
2006-06-01 — Assigned to lie
2006-06-04 — Law office publication review completed
2006-07-05 — Notice of publication
2006-07-25 — Published for opposition
2006-10-17 — Noa mailed - sou required from applicant
2007-03-12 — Sou teas extension received
2007-03-12 — Sou extension 1 filed
2007-03-12 — Sou extension 1 granted
2007-10-17 — Sou teas extension received
2007-10-17 — Sou extension 2 filed
2007-10-17 — Sou extension 2 granted
2008-03-18 — Sou teas extension received
2008-03-18 — Sou extension 3 filed
2008-03-18 — Sou extension 3 granted
2008-10-09 — Sou teas extension received
2008-10-09 — Sou extension 4 granted
2008-10-09 — Sou extension 4 filed
2009-04-17 — Sou teas extension received
2009-04-17 — Sou extension 5 filed
2009-04-17 — Sou extension 5 granted
2009-11-16 — Application abandoned
2009-11-16 — Application abandoned
2009-11-16 — Final status recorded
Owner Information
Blistex Inc.
Oak Brook , IL
Blistex Inc.
Oak Brook , IL
Correspondent
Burton S. Ehrlich Ladas & Parry LLP 224 S Michigan Avenue Suite 1600 Chicago, IL 60604
Filing Details
Filing Date:
2005-11-15
Status Date:
2009-11-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.